President Trump signs an executive order aimed at lowering drug prices, prompting discussions about Big Pharma's potential response and the broader implications for American healthcare costs.

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries that suppress drug prices.

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or discriminatory” practices by foreign countries that result in Americans paying far higher costs for prescription drugs.